Report
By Sofia Imad, Shilpa Rao, Vibhav Mariwala, Mrunalini Chaudhari, Mahesh Kalsekar, Rohit Bajoria & Supriya Shinde
With a vaccine sector valued at ~INR 95 billion, India is a global leader in vaccine manufacturing and production. However, will this infrastructure and capacity be able to deliver the COVID-19 vaccine in a timely manner?